ESAIY (Eisai Co) Accounts Receivable : $1,366 Mil (As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Eisai Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Eisai Co's accounts receivables for the quarter that ended in Sep. 2024 was $1,366 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Eisai Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 was 90.89.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Eisai Co's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was $0.06.

Eisai Co Accounts Receivable Historical Data

The historical data trend for Eisai Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eisai Co Accounts Receivable Chart

Eisai Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Accounts Receivable

Get a 7-Day Free Trial

1,672.02

1,474.81

1,753.71

1,400.94

1,449.81

Eisai Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Receivable	Get a 7-Day Free Trial															1,298.05	1,293.10	1,449.81	-	1,365.62

Eisai Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Eisai Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Eisai Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1365.621	/	1371.028	*	91
=	90.89

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Eisai Co's accounts receivable are only considered to be worth 75% of book value:

Eisai Co's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1882.745	+	0.75 * 1365.621	+	0.5 * 1343.726	-	3337.402
-	0	-	169.719)	/	1128.22
=	0.06

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Eisai Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Eisai Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Eisai Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eisai Co Ltd (OTCPK:ESAIY) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

ESALF:USA 4523:Japan EIIA:Germany EII:Germany EII:Germany

Address

4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088

Website

http://www.eisai.co.jp

Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.